Antibodies to muscle acetylcholine receptors, to other muscle antigens, and
to some cytokines are found in the majority of patients with thymic tumors
(thymomas) and myasthenia gravis (MG), The role of the tumor in initiating
autoimmunity, however, is unclear; in particular, it is not known whether
the thymoma exports mature and long-lived T cells, which could provide help
for antibody production in the periphery. Here, we quantified recently exp
orted thymic T cells using the approach of measuring episomal DNA fragments
[T-cell receptor excision circles (TRECs)], generated by T-cell receptor g
ene rearrangement, Compared to values in healthy individuals (n = 10) or in
patients with late-onset MG (n = 8), TREC levels were significantly raised
in both the CD4(+) and CD8(+) peripheral blood compartments of patients wi
th thymoma and MG (n = 14, p = 0.002 and p = 0.0004 compared to healthy con
trols) but only in the CD8+ compartment of the three patients with thymoma
without MG (p = 0.4 and p = 0.01 for CD4(+) and CD8(+)). TREC levels decrea
sed following thymectomy to values similar to controls but were substantial
ly raised in patients who had developed tumor recurrence (n = 6, p = 0.04 a
nd p = 0.02 for CD4(+) and CD8(+))(3) this was associated with increased an
tibodies to interferon-alpha and interleukin-12 in the one case studied ser
ially, Collectively, these results support the hypothesis that the neoplast
ic thymoma tissue itself can generate and export mature, long-lived T cells
and that these T cells reflect the thymic pathology and are likely to be r
elated to the associated autoimmune diseases. The results also provide a ne
w approach for early diagnosis of thymoma recurrence.